Evolus

Irvine, United States

Evolus medical aesthetics focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments.

$150.0M raised

May 2025

Post-IPO Debt

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Evolus raised?

Evolus has raised $150.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in May 2025.

Who are Evolus's investors?

Evolus's investors include Oxford Finance LLC, Pharmakon Advisors.

Where is Evolus headquartered?

Evolus is headquartered in Irvine, United States.

What does Evolus do?

Evolus medical aesthetics focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments.

What stage is Evolus at?

Evolus is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 5, 2025.

MLA

"Evolus — Funding & Investors." VCBacked, May 5, 2025, https://www.vcbacked.co/company/evolus. Accessed July 2, 2026.

APA

VCBacked. (2025). Evolus — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/evolus

Wikipedia (cite web)

{{cite web |title=Evolus — Funding & Investors |url=https://www.vcbacked.co/company/evolus |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 5, 2025.